Výsledky vyhledávání - Dang, Tan An

Upřesnit hledání
  1. 1
    Diagnosis delays in childhood cancer

    Diagnosis delays in childhood cancer Autor Tam Dang‐Tan, Eduardo L. Franco

    Vydáno 2007
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Synthesis of Intelligent pH Indicative Films from Chitosan/Poly(vinyl alcohol)/Anthocyanin Extracted from Red Cabbage

    Synthesis of Intelligent pH Indicative Films from Chitosan/Poly(vinyl alcohol)/Anthocyanin Extracted from Red Cabbage Autor Vo, Thuy-Vi, Dang, Tan-Hiep, Chen, Bing-Hung

    Vydáno 2019
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review

    Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review Autor Tam Dang‐Tan, Afisi Ismaila, Shiyuan Zhang, Victoria Zarotsky, Mark Bernauer

    Vydáno 2015
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review

    Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review Autor Dang-Tan, Tam, Ismaila, Afisi, Zhang, Shiyuan, Zarotsky, Victoria, Bernauer, Mark

    Vydáno 2015
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States

    Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States Autor Sarah N Ali, Tam Dang‐Tan, William J. Valentine, Brian Bekker Hansen

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years

    Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years Autor Li, Qian, Ganguly, Rahul, Ganz, Michael L., Gamble, Cory, Dang-Tan, Tam

    Vydáno 2018
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States

    Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States Autor Ali, Sarah Naz, Dang-Tan, Tam, Valentine, William J., Hansen, Brian Bekker

    Vydáno 2020
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Correction to: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA

    Correction to: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treat... Autor Johansen, Pierre, Hunt, Barnaby, Iyer, Neeraj N., Dang-Tan, Tam, Pollock, Richard F.

    Vydáno 2019
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  9. 9
    A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA

    A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in... Autor Johansen, Pierre, Hunt, Barnaby, Iyer, Neeraj N., Dang-Tan, Tam, Pollock, Richard F.

    Vydáno 2019
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational Study

    Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observati... Autor Dang-Tan, Tam, Kamble, Pravin S., Meah, Yunus, Gamble, Cory, Ganguly, Rahul, Horter, Libby

    Vydáno 2019
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Impact of Weight Change in Adults with Type 2 Diabetes Mellitus: A Literature Review and Critical Analysis

    Impact of Weight Change in Adults with Type 2 Diabetes Mellitus: A Literature Review and Critical Analysis Autor Fridman, Moshe, Lucas, Mariann E, Paprocki, Yurek, Dang-Tan, Tam, Iyer, Neeraj N

    Vydáno 2020
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis

    Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis Autor Solomon Nuhoho, Jatin Gupta, Brian Bekker Hansen, M Fletcher-Louis, Tam Dang‐Tan, Abby Paine

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States

    Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States Autor Wilkinson, Lars, Hunt, Barnaby, Johansen, Pierre, Iyer, Neeraj N., Dang-Tan, Tam, Pollock, Richard F.

    Vydáno 2018
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective

    Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective Autor Shah, Dhvani, Risebrough, Nancy A, Perdrizet, Johnna, Iyer, Neeraj N, Gamble, Cory, Dang-Tan, Tam

    Vydáno 2018
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis

    Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis Autor Nuhoho, Solomon, Gupta, Jatin, Hansen, Brian Bekker, Fletcher-Louis, Mary, Dang-Tan, Tam, Paine, Abby

    Vydáno 2019
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Functional evaluation of GUCY1A3 mutations associated with myocardial infarction risk

    Functional evaluation of GUCY1A3 mutations associated with myocardial infarction risk Autor Wobst, Jana, Dang, Tan An, Kessler, Thorsten, Ameln, Simon von, Tennstedt, Stephanie, Hengstenberg, Christian, Erdmann, Jeanette, Schunkert, Heribert

    Vydáno 2015
    Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Evaluation of the Cost Per Patient Achieving Treatment Targets with Oral Semaglutide: A Short-Term Cost-Effectiveness Analysis in the United States

    Evaluation of the Cost Per Patient Achieving Treatment Targets with Oral Semaglutide: A Short-Term Cost-Effectiveness Analysis in the United States Autor Hunt, Barnaby, Hansen, Brian B., Ericsson, Åsa, Kallenbach, Klaus, Ali, Sarah N., Dang-Tan, Tam, Malkin, Samuel J. P., Valentine, William J.

    Vydáno 2019
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Investigating the impact of a mutation in PDE5A on myocardial infarction

    Investigating the impact of a mutation in PDE5A on myocardial infarction Autor Dang, Tan A, Wobst, Jana, Kessler, Thorsten, Ameln, Simon V, Lehm, Manuel, Prestel, Matthias, Braenne, Ingrid, Aherrahrou, Redouane, Dichgans, Martin, Hengstenberg, Christian, Erdmannn, Jeanette, Schunkert, Heribert

    Vydáno 2015
    Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment

    Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment Autor Nguyen, Dang Tan, Le, Thi Khanh, Paris, Clément, Cherif, Chaïma, Audebert, Stéphane, Oluchi Udu-Ituma, Sandra, Benizri, Sébastien, Barthélémy, Philippe, Bertucci, François, Taïeb, David, Rocchi, Palma

    Vydáno 2021
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Developing monitoring and evaluation tools for event-based surveillance: experience from Vietnam

    Developing monitoring and evaluation tools for event-based surveillance: experience from Vietnam Autor Clara, Alexey, Dao, Anh T. P., Mounts, Anthony W., Bernadotte, Christina, Nguyen, Huyen T., Tran, Quy M., Tran, Quang D., Dang, Tan Q., Merali, Sharifa, Balajee, S. Arunmozhi, Do, Trang T.

    Vydáno 2020
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: